48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Surgical resection is considered standard therapy for cases of resectable unicentric Castleman’s disease (UCD). Unresectable cases of UCD do not have a consensus regarding the optimal treatment approach, but have utilized steroids, observation, chemotherapy, and radiotherapy. Here we discuss a patient presentation of UCD treated with an advanced radiotherapy technique, IMRT.

          Case report

          A 47 year old female was found to have an intra-thoracic posterior UCD and was determined not to be a good surgical candidate. She was referred for radiotherapy and was treated using IMRT to a total dose of 4320 cGy in 180 cGy fractions including a scheduled 10 day break. Following the break, the patient’s treatment was replanned at which the initial treatment volume was reduced by 50.9% for the duration of the treatment course. Radiation Therapy Oncology Group (RTOG) grade III pneumonitis developed which was managed medically. Neither disease progression nor late effects have occurred.

          Conclusions

          The use of IMRT and planned treatment break was successful in the treatment of a case of UCD, and should be considered for other unresectable cases.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          Localized mediastinal lymphnode hyperplasia resembling thymoma.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.

              Fifty years ago, Dr Benjamin Castleman first described the unusual lymphoproliferative disorder that now bears his name. Over the subsequent decades, astute clinical and pathologic observations coupled with clever molecular biologic research have increased our understanding of the aetiology of Castleman disease (CD). This article proposes three broad CD variants based on both distinctive histopathology and clinical behaviour. The pivotal roles of infection with human herpesvirus 8 and interleukin-6 production in the development of CD are emphasized. Finally, the natural history of CD and the myriad of therapeutic options are reviewed in the context of a unified model of CD pathophysiology, and continued areas of uncertainty are discussed.
                Bookmark

                Author and article information

                Journal
                Radiol Oncol
                Radiol Oncol
                RADO
                Radiology and Oncology
                Versita, Warsaw
                1318-2099
                1581-3207
                02 January 2012
                September 2012
                : 46
                : 3
                : 265-270
                Affiliations
                Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
                Author notes
                Correspondence to: Chance Matthiesen M.D., Department of Radiation Oncology, Peggy and Charles Stephenson Oklahoma Cancer Center, 800 N.E. 10th Street, OKCC L100, Oklahoma City, OK 73104, USA. Phone: +1 405-271-3016; Fax: +1 405-271-8297; E-mail: chance-matthiesen@ 123456ouhsc.edu

                Disclosure: No potential conflicts of interest were disclosed.

                Article
                rado-46-03-265
                10.2478/v10019-012-0008-0
                3472945
                23077466
                51dc690c-8ef2-47bc-a228-97768c0187f2
                Copyright © by Association of Radiology & Oncology

                This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/3.0/).

                History
                : 25 September 2011
                : 17 October 2011
                Categories
                Case Report

                Oncology & Radiotherapy
                castleman’s disease,imrt
                Oncology & Radiotherapy
                castleman’s disease, imrt

                Comments

                Comment on this article